Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 |
filingDate |
2012-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101969515-B1 |
titleOfInvention |
Treatment of coagulation disease by administration of recombinant vwf |
abstract |
The present invention provides a method of treating a coagulation disorder comprising hemophilia and von Willebrand disease by administering recombinant von Willebrand factor alone or in combination with Factor VIII. |
priorityDate |
2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |